XML 36 R30.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Segment Information (Tables) | 6 Months Ended
--- | ---
Dec. 31, 2014
Segment Reporting [Abstract] |  |
Revenue by Reportable Segment | The following tables present revenue for each reportable segment and Corporate:
| Three Months Ended December 31
(in millions) | 2014 |  | 2013
Pharmaceutical | $ | 22,627 |  |  | $ | 19,443 |
Medical | 2,914 |  |  | 2,799 |
Total segment revenue | 25,541 |  |  | 22,242 |
Corporate (1) | (4 | ) |  | (2 | )
Total revenue | $ | 25,537 |  |  | $ | 22,240 |
| Six Months Ended December 31
(in millions) | 2014 |  | 2013
Pharmaceutical (2) | $ | 43,836 |  |  | $ | 41,256 |
Medical | 5,766 |  |  | 5,511 |
Total segment revenue | 49,602 |  |  | 46,767 |
Corporate (1) | 5 |  |  | (4 | )
Total revenue | $ | 49,607 |  |  | $ | 46,763 |
(1) | Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
(2) | Our pharmaceutical distribution contract with Walgreen Co. expired on August 31, 2013.
| [1]
Segment Profit by Reportable Segment | The following tables present segment profit by reportable segment and Corporate:
| Three Months Ended December 31
(in millions) | 2014 |  | 2013
Pharmaceutical | $ | 542 |  |  | $ | 482 |
Medical | 115 |  |  | 131 |
Total segment profit | 657 |  |  | 613 |
Corporate | (111 | ) |  | (94 | )
Total operating earnings | $ | 546 |  |  | $ | 519 |
| Six Months Ended December 31
(in millions) | 2014 |  | 2013
Pharmaceutical | $ | 992 |  |  | $ | 916 |
Medical | 229 |  |  | 238 |
Total segment profit | 1,221 |  |  | 1,154 |
Corporate | (209 | ) |  | (164 | )
Total operating earnings | $ | 1,012 |  |  | $ | 990 |
| [1]
[1] | Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total profit or loss from reportable segments, to the entity's consolidated income before income taxes, extraordinary items, and discontinued operations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration